Author

Howard E. Gendelman

Professor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center - Cited by 52,063 - Neuroimmune Pharmacology

Biography

Howard E. Gendelman is affiliated to Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, Nebraska, USA . He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
The 2022 outbreak and the pathobiology of the monkeypox virus
N Kumar, A Acharya, HE Gendelman, SN ByrareddyJournal of autoimmunity 131, 102855, 2022202
246
2022
Introducing NeuroImmune Pharmacology and Therapeutics (NIPT), the official journal of the Society on NeuroImmune Pharmacology (SNIP)
SL Chang, HE Gendelman, S KumarNeuroImmune Pharmacology and Therapeutics 1 (1), 1-2, 2022202
42
2022
Defining the innate immune responses for SARS-CoV-2-human macrophage interactions
MM Abdelmoaty, P Yeapuri, J Machhi, KE Olson, F Shahjin, V Kumar, ...Frontiers in immunology 12, 741502, 2021202
33
2021
CD4+ effector T cells accelerate Alzheimer’s disease in mice
J Machhi, P Yeapuri, Y Lu, E Foster, R Chikhale, J Herskovitz, ...Journal of Neuroinflammation 18 (1), 1-23, 2021202
31
2021
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
DA Cobb, N Smith, S Deodhar, AN Bade, N Gautam, BLD Shetty, ...Nature communications 12 (1), 5458, 2021202
22
2021
Oral antivirals for the prevention and treatment of SARS-CoV-2 infection
V Soriano, C De-Mendoza, B Edagwa, A Treviño, P Barreiro, ...AIDS reviews 24 (1), 41, 2022202
19
2022
CRISPR-Cas9 mediated exonic disruption for HIV-1 elimination
J Herskovitz, M Hasan, M Patel, WR Blomberg, JD Cohen, J Machhi, ...EBioMedicine 73, 2021202
16
2021
Humanized mice for infectious and neurodegenerative disorders
PK Dash, S Gorantla, L Poluektova, M Hasan, E Waight, C Zhang, ...Retrovirology 18 (1), 1-17, 2021202
15
2021
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
S Deodhar, B Sillman, AN Bade, SN Avedissian, AT Podany, ...Nature communications (1), 3226, 2022202
13
2022
The immunopathobiology of SARS-CoV-2 infection
M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ...FEMS Microbiology Reviews 45 (6), fuab035, 2021202
11
2021
Europium-doped cerium oxide nanoparticles for microglial amyloid beta clearance and homeostasis
J Machhi, P Yeapuri, M Markovic, M Patel, W Yan, Y Lu, JD Cohen, ...ACS chemical neuroscience 13 (), 1232-1244, 2022202
8
2022
Dolutegravir inhibition of matrix metalloproteinases affects mouse neurodevelopment
AN Bade, JEM McMillan, Y Liu, BJ Edagwa, HE GendelmanMolecular Neurobiology 58 (11), 503-521, 2021202
7
2021
A link between methylglyoxal and heart failure during HIV-1 infection
PK Dash, FA Alomar, JL Cox, JE McMillan, BT Hackfort, E Makarov, ...Frontiers in Cardiovascular Medicine 8, 792180, 2021202
6
2021
Animal models for studies of HIV-1 brain reservoirs
E Waight, C Zhang, S Mathews, BD Kevadiya, KCK Lloyd, HE Gendelman, ...Journal of Leukocyte Biology 112 (), 128-129, 2022202
5
2022
Recovery of latent HIV-1 from brain tissue by adoptive cell transfer in virally suppressed humanized mice
H Su, S Sravanam, B Sillman, E Waight, E Makarov, S Mathews, ...Journal of Neuroimmune Pharmacology, 1-10, 2021202
5
2021
Multipolymer microsphere delivery of SARS-CoV-2 antigens
F Shahjin, M Patel, J Machhi, JD Cohen, MU Nayan, P Yeapuri, C Zhang, ...Acta Biomaterialia 158, 93-509, 2023202
4
2023
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
S Das, W Wang, M Ganesan, F Fonseca-Lanza, DA Cobb, G Bybee, ...Science Advances 8 (51), eade9582, 2022202
3
2022
Prodrug therapies for infectious and neurodegenerative diseases
M Markovic, S Deodhar, J Machhi, P Yeapuri, M Saleh, B J. Edagwa, ...Pharmaceutics 14 (), 518, 2022202
3
2022
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
M Markovic, P Yeapuri, KL Namminga, Y Lu, M Saleh, KE Olson, ...NeuroImmune Pharmacology and Therapeutics 1 (1), 4-50, 2022202
3
2022
HIV-1 integrase strand transfer inhibitors and neurodevelopment
EG Foster, HE Gendelman, AN BadePharmaceuticals 15 (12), 15, 2022202
3
2022

Referred From: https://scholar.google.co.in/citations?user=J9ULkfEAAAAJ&hl=en

Cited by
Citations 52063
h-index 116
i10-index 441
Open Access Journals